Related Experiment Video
Updated: Jul 31, 2025

06:52
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
6.6K
Utility of Gene Expression Profiling in Skin Cancer: A Comprehensive Review.
Journal of Drugs in Dermatology : JDD
|May 3, 2023
Summary
Gene expression profiling (GEP) advances skin cancer management by analyzing RNA transcripts. This technology enhances diagnosis and prognosis of skin cancers, improving patient outcomes.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Metastatic potential in skin cancer necessitates advanced diagnostic tools.
- Gene expression profiling (GEP) offers innovative insights into skin cancer tumor biology.
- Current methods rely on ribonucleic acid (RNA) transcript quantification.
Approach:
- Utilizes reverse transcriptase-polymerase chain reaction to convert RNA to deoxyribonucleic acid (DNA) for quantification.
- Incorporates RNA-sequencing (RNA-seq) for measuring known sequences and identifying novel genes.
- Requires minimal RNA input and demonstrates high reproducibility.
Key Points:
- GEP aids in understanding skin cancer's metastatic potential.
- RNA-seq expands genomic knowledge by detecting novel genes.
- Several GEPs are developed to improve skin cancer diagnosis and prognosis.
Conclusions:
- GEP is a valuable tool for advancing skin cancer research and clinical application.
- The technology enhances the understanding of skin cancer biology, aiding in patient management.
- Ongoing investigations aim to further integrate GEP into clinical practice for improved outcomes.

